Skip to main content

Morgan Stanley Sticks to Their Sell Rating for Petmed Express (PETS)

Tipranks - Tipranks - Thu Apr 17, 2025

Morgan Stanley analyst Erin Wright maintained a Sell rating on Petmed Express (PETS – Research Report) today and set a price target of $3.50. The company’s shares closed yesterday at $3.04.

Stay Ahead of the Market:

Wright covers the Healthcare sector, focusing on stocks such as Zoetis, Align Tech, and Cencora. According to TipRanks, Wright has an average return of 13.5% and a 64.40% success rate on recommended stocks.

Currently, the analyst consensus on Petmed Express is a Hold with an average price target of $4.00.

See today’s best-performing stocks on TipRanks >>

The company has a one-year high of $6.85 and a one-year low of $2.90. Currently, Petmed Express has an average volume of 256.5K.

Based on the recent corporate insider activity of 25 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of PETS in relation to earlier this year. Last month, NINA CAPITAL HOLDINGS INC., a Major Shareholder at PETS bought 100,000.00 shares for a total of $408,000.00.

Read More on PETS:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).